rs75713718
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_198271.5(LMOD3):āc.1257G>Cā(p.Met419Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000677 in 1,613,846 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0035 ( 1 hom., cov: 31)
Exomes š: 0.00038 ( 4 hom. )
Consequence
LMOD3
NM_198271.5 missense
NM_198271.5 missense
Scores
2
6
10
Clinical Significance
Conservation
PhyloP100: 5.70
Genes affected
LMOD3 (HGNC:6649): (leiomodin 3) The protein encoded by this gene is a member of the leiomodin family of proteins. This protein contains three actin-binding domains, a tropomyosin domain, a leucine-rich repeat domain, and a Wiskott-Aldrich syndrome protein homology 2 domain (WH2). Localization of this protein to the pointed ends of thin filaments has been observed, and there is evidence that this protein acts as a catalyst of actin nucleation, and is important to the organization of sarcomeric thin filaments in skeletal muscles. Mutations in this gene have been associated as one cause of Nemaline myopathy, as other genes have also been linked to this disorder. Nemaline myopathy is a disorder characterized by nonprogressive generalized muscle weakness and protein inclusions (nemaline bodies) in skeletal myofibers. Patients with mutations in this gene often present with a severe congenital form of the disorder. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.008024842).
BP6
Variant 3-69119098-C-G is Benign according to our data. Variant chr3-69119098-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 475298.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00352 (536/152142) while in subpopulation AFR AF= 0.0124 (513/41482). AF 95% confidence interval is 0.0115. There are 1 homozygotes in gnomad4. There are 259 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMOD3 | NM_198271.5 | c.1257G>C | p.Met419Ile | missense_variant | 2/3 | ENST00000420581.7 | NP_938012.2 | |
LMOD3 | NM_001304418.3 | c.1257G>C | p.Met419Ile | missense_variant | 3/4 | NP_001291347.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMOD3 | ENST00000420581.7 | c.1257G>C | p.Met419Ile | missense_variant | 2/3 | 1 | NM_198271.5 | ENSP00000414670 | P1 | |
LMOD3 | ENST00000475434.1 | c.1257G>C | p.Met419Ile | missense_variant | 3/4 | 5 | ENSP00000418645 | P1 | ||
LMOD3 | ENST00000489031.5 | c.1257G>C | p.Met419Ile | missense_variant | 3/4 | 2 | ENSP00000417210 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00347 AC: 527AN: 152024Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
527
AN:
152024
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000827 AC: 206AN: 249146Hom.: 1 AF XY: 0.000644 AC XY: 87AN XY: 135164
GnomAD3 exomes
AF:
AC:
206
AN:
249146
Hom.:
AF XY:
AC XY:
87
AN XY:
135164
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000381 AC: 557AN: 1461704Hom.: 4 Cov.: 33 AF XY: 0.000338 AC XY: 246AN XY: 727132
GnomAD4 exome
AF:
AC:
557
AN:
1461704
Hom.:
Cov.:
33
AF XY:
AC XY:
246
AN XY:
727132
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00352 AC: 536AN: 152142Hom.: 1 Cov.: 31 AF XY: 0.00348 AC XY: 259AN XY: 74392
GnomAD4 genome
AF:
AC:
536
AN:
152142
Hom.:
Cov.:
31
AF XY:
AC XY:
259
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
48
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
113
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 04, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | LMOD3: BS1 - |
Nemaline myopathy 10 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;.;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Benign
T;T;T
Polyphen
D;D;D
Vest4
MutPred
Loss of sheet (P = 0.0084);Loss of sheet (P = 0.0084);Loss of sheet (P = 0.0084);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at